These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5087197)

  • 41. [Granulocytopoiesis in chronic uremia patients undergoing periodic hemodialysis (granulocyte kinetics studied with Se75-seleniomethionine)].
    Lusvarghi E; Mauri C; Senter M; Curci G; Sacchi S; Davoli D; Furci M; Grosoli M
    Minerva Nefrol; 1982; 29(4):205-10. PubMed ID: 7155440
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of uremia with chronic hemodialysis.
    Sadler JH
    J Med Assoc Ga; 1966 Nov; 55(11):484. PubMed ID: 5978853
    [No Abstract]   [Full Text] [Related]  

  • 43. [Prophylactic and conservative treatment of arteriovenous shunts in chronic kidney disease patients treated with periodic hemodialysis].
    Ancona G
    Chir Patol Sper; 1966; 14(7):246-65. PubMed ID: 5990179
    [No Abstract]   [Full Text] [Related]  

  • 44. [Evaluation of the management of chronic uremia. 3. Role of hemodialysis in the management of chronic uremia].
    Villarreal H
    Gac Med Mex; 1967 Dec; 97(12):1604-8. PubMed ID: 5611802
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunological aspects in various forms of shock.
    Santaella ML; Cox RA
    Bol Asoc Med P R; 1986 Apr; 78(4):149-51. PubMed ID: 3459472
    [No Abstract]   [Full Text] [Related]  

  • 46. [Limitations of prolonged extrarenal hemodialysis in patients with terminal chronic uremia].
    Casciani C
    Minerva Med; 1967 Jun; 58(45):2096-7. PubMed ID: 6028364
    [No Abstract]   [Full Text] [Related]  

  • 47. [Septic shock in a patient treated by repeated hemodialysis].
    Majdan M; Ksiazek A; Twardowski Z
    Wiad Lek; 1979 Sep; 32(17):1229-32. PubMed ID: 506261
    [No Abstract]   [Full Text] [Related]  

  • 48. [On the fate of arteriovenous prosthesis for periodic hemodialysis].
    Ferrero R; Pierini A; Poletti GA; Giachino G
    Minerva Chir; 1969 Dec; 24(24):1436-41. PubMed ID: 5374073
    [No Abstract]   [Full Text] [Related]  

  • 49. Hemodialysis for chronic uremia in Arizona, past, present and future.
    Johnson KE; Potter DJ
    Ariz Med; 1967 Jun; 24(6):531-5. PubMed ID: 6046012
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of terminal-stage uremia by substitution dialysis methods in France in December 1981].
    Jacobs C; Patte R
    Nephrologie; 1983; 4(2):64-8. PubMed ID: 6877480
    [No Abstract]   [Full Text] [Related]  

  • 51. [The vicious circles of shock. Their treatment with high doses of hydrocortisone hemisuccinate combined with isoprenaline].
    Doumont JM; de Cannière P
    Brux Med; 1972 Sep; 52(9):621-32. PubMed ID: 5070178
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acid-base equilibrium in uremia: effect of continuous ambulatory peritoneal dialysis and hemodialysis].
    Nin Ferrari J; Santoro A; Fabbri L; Cavilli F; Zucchelli P
    G Clin Med; 1981 Sep; 62(9):624-33. PubMed ID: 7319174
    [No Abstract]   [Full Text] [Related]  

  • 53. Laboratory predictors of relative adrenal insufficiency in septic shock.
    Fessler MB; O'Brien JM; Douglas IS
    Crit Care Med; 2003 Aug; 31(8):2251-2; author reply 2252-3. PubMed ID: 12973195
    [No Abstract]   [Full Text] [Related]  

  • 54. [Arteriovenous fistula of the forearm in periodic hemodialysis].
    Mioli V; Reggiani A; Rusconi R; Vangelista A; Albertazzi A
    Minerva Nefrol; 1969; 16(4):271-85. PubMed ID: 5397047
    [No Abstract]   [Full Text] [Related]  

  • 55. [Behavior of intraocular pressure during hemodialysis in patients with chronic uremia].
    Biagini M; Gloria EM
    Ann Ottalmol Clin Ocul; 1967 Jul; 93(7):705-13. PubMed ID: 5605002
    [No Abstract]   [Full Text] [Related]  

  • 56. [Study of the blood platelets in chronic dialyzed patients before and after hemodialysis. Comparison with a group of patients with grave chronic uremia treated with occasional dialysis].
    Praga C; Brancaccio D; Pogliani E; Della Grazia M
    Minerva Nefrol; 1968; 15(5):322-6. PubMed ID: 5743459
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current views on the effectiveness of hemodialysis in the treatment of chronic uremia].
    Segoloni G; Ragni R; Stratta P; Triolo G; Giachino G; Piccoli G
    Arch Sci Med (Torino); 1971; 128(4):175-80. PubMed ID: 5154430
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapy of acute kidney failure].
    Precht K; Buder HW
    Z Arztl Fortbild (Jena); 1971 Aug; 65(16):830-2. PubMed ID: 5142692
    [No Abstract]   [Full Text] [Related]  

  • 59. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
    Meyer S; Löffler G; Polcher T; Gottschling S; Gortner L
    Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Practical method and problems encountered in 10 cases of terminal chronic uremia treated by a long-term hemodialysis program].
    Nakajima K; Sakamoto Y
    Naika; 1967 Oct; 20(4):655-64. PubMed ID: 5588536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.